美國FDA批準的CAR-T隻針對某幾種淋巴癌.

. CAR T-cell therapies are FDA approved for:

  • Aggressive relapsed or refractory large B-cell lymphoma including diffuse large B cell lymphoma (DLBCL), primary mediastinal B-cell lymphoma, high-grade B-cell lymphoma, and transformed follicular lymphoma.
  • Relapsed or refractory mantle cell lymphoma
  • Relapsed or refractory follicular lymphoma

所有跟帖: 

謝謝你的信息和回複! -錸銦- 給 錸銦 發送悄悄話 (0 bytes) () 12/12/2023 postreply 22:45:24

請您先登陸,再發跟帖!